Atropine comes in a vial with a concentration of __ mg/mL.
1 mg per mL
Atropine MOA: Atropine is an ___. Increased ACh d/t reversal agents stimulates muscarinic receptors of the ___, __, and __.
These parasympathetic effects are unwanted during reversal therefore atropine is administered to block __, __, and __muscarinic ACh receptors.
anticholinergic
M2 in heart: bradycardia
M3 in glands: salivation & bronchial secretions
M3 in gut: cramping & diarrhea
Atropine duration of action is approx __ to __ minutes.
30 to 60 minutes
Atropine is paired with which acetylcholinesterase inhibitor for reversal of paralytics?
What is the dose of atropine used?
Edrophonium
7 to 10 mcg/kg
M2 in heart: ___
M3 in glands: __ & __
M3 in gut: __ & __
M2 in heart: bradycardia
M3 in glands: salivation & bronchial secretions
M3 in gut: cramping & diarrhea
The atropine dose for bradycardia is ___ mg IV. Repeat every __ to __ minutes as needed.
The maximum total dose: __ mg.
1 mg IV q 3-5 minutes
max dose 3 mg
T/F: Atropine is preferred for bradycardia in cardiac patients.
False because it can cause tachycardia or myocardial oxygen demand spikes TOO fast.
Glycopyrrolate > atropine
1. Slower, more controlled increase in HR
2. Less risk of tachyarrhythmias
3. Better for patients with coronary artery disease or limited cardiac reserve